David M. Knott Jr’s Coherus Oncology CHRS Stock Holding History

David M. Knott Jr’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-106,185	Closed	-$254K	–	101
2024 Q1	$254K	Sell	106,185 -420,127	-80%	-$1.03M	0.09%	61
2023 Q4	$1.75M	Sell	526,312 -103,688	-16%	-$278K	0.67%	24
2023 Q3	$2.36M	Buy	630,000 +384,990	+157%	+$1.78M	0.9%	18
2023 Q2	$1.05M	Buy	+245,010	New	+$1.45M	0.42%	41
2023 Q1	–	Sell	-128,517	Closed	-$1.02M	–	156
2022 Q4	$1.02M	Sell	128,517 -71,483	-36%	-$550K	0.38%	44
2022 Q3	$1.92M	Buy	200,000 +13,866	+7%	+$140K	0.81%	27
2022 Q2	$1.35M	Buy	186,134 +68,579	+58%	+$596K	0.57%	43
2022 Q1	$1.52M	Buy	117,555 +15,000	+15%	+$191K	0.48%	50
2021 Q4	$1.64M	Buy	+102,555	New	+$1.79M	0.56%	45

Other funds holding CHRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David M. Knott Jr's CHRS Position: Q2 2024 in Review

David M. Knott Jr sold out of Coherus Oncology (CHRS) in Q2 2024, closing a stake of 106,185 shares — an estimated $254K sold.

David M. Knott Jr first reported a position in CHRS in Q4 2021 and held it in 9 quarters. The position peaked at $2.36M in Q3 2023. 135 funds tracked by Wall St. Rank hold CHRS as of Q2 2024.

David M. Knott Jr reported no remaining Coherus Oncology position as of Q2 2024 after selling out during the quarter.
David M. Knott Jr sold 106,185 Coherus Oncology shares in Q2 2024, an estimated $254K.
David M. Knott Jr first reported a position in Coherus Oncology in Q4 2021 and held it in 9 quarters.
David M. Knott Jr's Coherus Oncology position peaked at $2.36M in Q3 2023.
135 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2024.

Based on David M. Knott Jr's 13F filing for Q2 2024, filed 12 Aug 2024.